(A) Bath addition of 20 µM L-APB (an mGluR group III agonist)
significantly slows release from cones in darkness
(p<0.05,
n = 13). The mGluR antagonist MSPG
(100 µM) has no effect on the dark release rate. (B) 20 µM
AMPA markedly increases the release rate from cones
(n = 16). The effect of AMPA is
blocked by 10 µM DNQX
(n = 10), leaving release
insignificantly changed from the control rate in darkness. (C)
Dose-response curve for release rate as a function of AMPA
concentration. N = 4–16 for
each concentration. (D–E) Bath addition of 10 µM DNQX
significantly slows release from cone terminals in darkness
(p<0.001,
n = 21), suggesting that the
physiological level of ambient glutamate boosts release. (F). High
K+ (50 mM) saline, which depolarizes cones,
accelerated release from cone terminals to twice the dark release rate
(n = 9). Addition of 10
µM DNQX greatly reduced the high K+ evoked-release
(p<0.01,
n = 7), suggesting that the
glutamate released by cones elicits positive feedback. In this and
subsequent figures, * denotes statistical significance of
p<0.05, while ** denotes
p<0.01.